1. Anderson DJ, Kaye KS, Classen D, et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29:S51-S61.
2. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for Prevention of Surgical Site Infection, 1999. Am J Infect Control. 1999;20(4):247-278.
3. Soper DE, Bump RC, Hurt WG. Wound infection after abdominal hysterectomy: effect of the depth of subcutaneous tissue. Am J Obstet Gynecol. 1995;173(2):465-469.
4. Molina-Cabrillana J, Valle-Morales L, Hernandez-Vera J, Lopez-Carrio I, Garcia-Hernandez JA, Bolanos-Rivero M. Surveillance and risk factors on hysterectomy wound infection rate in Gran Canaria, Spain. Eur J Obstet Gynecol Reprod Biol. 2008;136(2):232-238.
5. Kandula PV, Wenzel RP. Postoperative wound infection after total abdominal hysterectomy: a controlled study of the increased duration of hospital stay and trends in postoperative wound infection. Am J Infect Control. 1993;21(4):201-204.
6. Shapiro M, Munoz A, Tager IB, Schoenbaum SC, Polk BF. Risk factors for infection at the operative site after abdominal or vaginal hysterectomy. N Engl J Med. 1982;307(27):1661-1666.
7. Persson E, Bergstrom M, Larsson PG, et al. Infections after hysterectomy: a prospective nation-wide Swedish study. The Study Group on Infectious Diseases in Obstetrics and Gynecology within the Swedish Society of Obstetrics and Gynecology. Acta Obstet Gynecol Scand. 1996;75(8):757-761.
8. Olsen MA, Higham-Kessler J, Yokoe D, et al. Developing a Risk Stratification Model for Surgical Site Infection after Abdominal Hysterectomy. Infect Control Hosp Epidemiol. 2009;30(11):1077-1083.
9. Olsen MA, Butler AM, Willers DM, Devkota P, Gross GA, Fraser VJ. Risk factors for surgical site infection after low transverse cesarean section. Infec Control Hosp Epidemiol. 2008;29(6):477-484.
10. Chaim W, Bashiri A, Bar-David J, I Shoham-Vardi, M Mazor. Prevalence and clinical significance of postpartum endometritis and wound infection. Infect Dis Obstet Gynecol. 2000;8(2):77-82.
11. Killian CA, Graffunder EM, Vinciguerra TJ, Venezia RA. Risk factors for surgical-site infections following cesarean section. Infect Control Hosp Epidemiol. 2001;22(10):613-617.
12. Lasley DS, Eblen A, Yancey MK, Duff P. The effect of placental removal method on the incidence of postcesarean infections. Am J Obstet Gynecol. 1997;176(6):1250-1254.
13. Myles TD, Gooch J, Santolaya J. Obesity as an independent risk factor for infectious morbidity in patients who undergo cesarean delivery. Obstet Gynecol. 2002;100(5 Pt 1):959-964.
14. Schneid-Kofman N, Sheiner E, Levy A, Holcberg G. Risk factors for wound infection following cesarean deliveries. Int J Gynaecol Obstet. 2005;90(1):10-15.
15. Tran TS, Jamulitrat S, Chongsuvivatwong V, Geater A. Risk factors for postcesarean surgical site infection. Obstet Gynecol. 2000;95(3):367-371.
16. Vermillion ST, Lamoutte C, Soper DE, Verdeja A. Wound infection after cesarean: effect of subcutaneous tissue thickness. Obstet Gynecol. 2000;95(6Pt 1):923-926.
17. Johnson A, Young D, Reilly J. Caesarean section surgical site infection surveillance. J Hosp Infect. 2006;64(1):30-35.
18. Polednak AP. Estimating the number of U.S. incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-related cancers. Cancer Detect Prev. 2008;32(3):190-199.
19. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and Trends in Obesity among US Adults, 1999-2008. JAMA. 2010;303(3):235-241.
20. Thomas EJ, Goldman L, Mangione CM, et al. Body mass index as a correlate of postoperative complications and resource utilization. Am J Med. 1997;102(3):2770-283.
21. Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis. 2006;6(7):438-446.
22. Forse RA, Karam B, MacLean LD, Christou NV. Antibiotic prohphylaxis for surgery in morbidly obese patients. Surgery. 1989;106(4):750-756.
23. Pevzner L, Swank M, Krepel C, Wing DA, Chan K, Edmiston CE Jr. Effects of Maternal Obesity on Tissue Concentrations of Prophylactic Cefazolin During Cesarean Delivery. Obstet Gynecol. 2011;117(4):877-882.
24. Weber WP, Zwahlen M, Reck S, et al. The association of preoperative anemia and perioperative allogeneic blood transfusion with the risk of surgical site infection. Transfusion. 2009;49(9):1964-1970.
25. Houbiers JG, Brand A, van deWatering LM, et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffycoat- depleted blood in surgery for colorectal cancer. Lancet. 1994;344(8922):573-578.
26. van deWatering LM, Hermans J, Houbiers JG, et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation. 1998;97(6):562-568.
27. Bilgin YM, van deWatering LM, Eijsman L, et al. Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Circulation. 2004;109(22):2755-2760.
28. van Hilten JA, van deWatering LM, van Bockel JH, et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ. 2004;328(7451):1281.
29. Swoboda SM, Merz C, Kostuik J, Trentler B, Lipsett PA. Does intraoperative blood loss affect antibiotic serum and tissue concentrations? Arch Surg. 1996;131(11):1165-1171.
30. Waters JH, Yazer M, Chen YF, Kloke J. Blood salvage and cancer surgery: a meta-analysis of available studies. Transfusion. 2012;52(10):2167-2173.
31. Anaya DA, Cormier JN, Xing Y, et al. Development and validation of a novel stratification tool for identifying cancer patients at increased risk of surgical site infection. Ann Surg. 2012;255(1):134-139.